Timothy Lynch

No open positions remaining

Net worth: 33 M $ as of 30/09/2026

56 year

75 connections

Health Technology

Finance

Consumer Services

Profile

Mr. Timothy P.
Lynch was previously employed as an Independent Director by InSite Vision, Inc., a Managing Member by Stonepine Capital Management LLC, an Independent Director by Nabi Biopharmaceuticals, an Independent Director by Allos Therapeutics, Inc., a President & Chief Executive Officer by Neurostat Pharmaceuticals, Inc., a President & Chief Executive Officer by Vivo Therapeutics, Inc., a Chief Financial Officer by Tercica, Inc., a Chief Financial Officer by InterMune, Inc., a Principal by Goldman Sachs & Co. LLC, and an Advisor by Healthcare Royalty Management LLC.
He also served on the board at Aradigm Corp., BioForm Medical, Inc., ClearFlow, Inc. and Elan Corp.
Plc.
He received his undergraduate degree from Colgate University and an MBA from Harvard University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
Evolus, Inc. Evolus, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurotoxins 5.93%	17/04/2026	3,835,363 ( 5.93% )	31 M $	30/09/2026
AEON Biopharma, Inc. AEON Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for neurology and gastroenterology markets 13.03%	19/08/2026	6,500,000 ( 13.03% )	2 M $	30/09/2026

Former positions of Timothy Lynch

Companies	Position	End
Stonepine Capital Management LLC Stonepine Capital Management LLC Investment ManagersFinance Stonepine aims to achieve superior absolute returns while preserving capital primarily by investing its assets in publicly traded healthcare companies. Their investment focus is companies with commercial stage products generating sustainable revenue and companies with substantial financial assets (such as cash and royalty income streams). The firm looks for companies whose valuations reflect a material discount to their fundamental value in the healthcare space.	Director of Investments	01/09/2024
Nabi Biopharmaceuticals Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products	Director/Board Member	31/12/2011
INSITE VISION INC.	Director/Board Member	16/09/2011
Allos Therapeutics, Inc. Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics	Director/Board Member	04/06/2009
BioForm Medical, Inc. BioForm Medical, Inc. Medical SpecialtiesHealth Technology Develops technology for soft and hard tissue augmentation	Director/Board Member	19/02/2010

See the detail of Timothy Lynch's experience

Education of Timothy Lynch

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Timothy Lynch's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	16
Elan Corp. Plc Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems	Health Technology
InSite Vision, Inc. InSite Vision, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceutical products	Health Technology
Nabi Biopharmaceuticals Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products	Health Technology
Aradigm Corp. Aradigm Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for the treatment and prevention of respiratory diseases	Health Technology
Allos Therapeutics, Inc. Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics	Health Technology
InterMune, Inc. InterMune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases	Health Technology
Tercica, Inc. Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders	Health Technology
BioForm Medical, Inc. BioForm Medical, Inc. Medical SpecialtiesHealth Technology Develops technology for soft and hard tissue augmentation	Health Technology
ClearFlow, Inc. ClearFlow, Inc. Medical SpecialtiesHealth Technology Develops ICU surgical and medical devices	Health Technology
Stonepine Capital Management LLC Stonepine Capital Management LLC Investment ManagersFinance Stonepine aims to achieve superior absolute returns while preserving capital primarily by investing its assets in publicly traded healthcare companies. Their investment focus is companies with commercial stage products generating sustainable revenue and companies with substantial financial assets (such as cash and royalty income streams). The firm looks for companies whose valuations reflect a material discount to their fundamental value in the healthcare space.	Finance
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Goldman Sachs & Co. LLC Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Colgate University Colgate University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Healthcare Royalty Management LLC Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt.	Finance
Neurostat Pharmaceuticals, Inc.
Vivo Therapeutics, Inc.